v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash at bank $ 9,098 $ 11,206
Prepayment 95,225 25,550
Total current assets 104,323 36,756
Cash and investments held in trust account 13,153,709 57,003,115
TOTAL ASSETS 13,258,032 57,039,871
Current liabilities:    
Accrued expenses 106,907 73,496
Extension promissory note payable 2,788,022 2,668,022
Total current liabilities 4,477,809 4,057,398
Deferred underwriting compensation 2,990,000 2,990,000
TOTAL LIABILITIES 7,467,809 7,047,398
Commitments and contingencies (Note 7)
Ordinary shares, 4,822,346 and 14,950,000 shares subject to possible redemption issued and outstanding as of December 31, 2025 and 2024, respectively 13,153,709 57,003,115
Shareholders’ Deficit:    
Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 4,416,075 shares issued and outstanding as of December 31, 2025 and 2024 (excluding 4,822,346 and 14,950,000 shares subject to possible redemption, respectively) 442 442
Accumulated deficit (7,363,928) (7,011,084)
Total Shareholders’ Deficit (7,363,486) (7,010,642)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT 13,258,032 57,039,871
Related Party    
Current liabilities:    
Amount due to a related party $ 1,582,880 $ 1,315,880